Serum uric acid still carries controversies about its role in endothelial dysfunction.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

1. Neutrophil to lymphocyte ratio may be predict of mortality in all conditions.British journal of cancer · 2013
   Article
2. Neutrophil to lymphocyte ratio may predict mortality in breast cancer patients.Journal of breast cancer · 2013
   Article
3. Comment on 'Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients': neutrophil to lymphocyte ratio may be predictor of mortality in patients with soft-tissue sarcoma.British journal of cancer · 2013
   Article

Corrections and comments

• Commented on by
  REPLY TO: Serum uric acid still carries controversies about its role in endothelial dysfunction.2013
• Comment on
  Serum uric acid, inflammation, and nondipping circadian pattern in essential hypertension.2013

Authors and funding

6 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as